The terrorist attacks in Paris may have finally spurred a brand change for Isis Pharmaceuticals Inc., a drugmaker that until now has steadfastly held on to its name even as the militant group rose in prominence in the Middle East. "We want the story to be about the medicines that we're creating, and not about our name," D. Wade Walke, a spokesman for the drugmaker, said in an interview on Wednesday.